MedTrace Logo

Integrating Pediatric TB Services Into Child Healthcare Services in Africa

NCT03862261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1715

Last updated 2022-03-23

No results posted yet for this study

Summary

Under-diagnosis of TB in children is a critical gap to address. The INPUT study is a multinational stepped-wedge cluster-randomized intervention study aiming to assess the effect of integrating TB services into child healthcare services on TB diagnosis capacities in children under 5 years of age.

Conditions

  • Tuberculosis
  • Children, Only
  • Diagnosis
  • Delivery of Health Care

Interventions

OTHER

Integrated pediatric TB services

pediatric TB services will be integrated into key child healthcare services: maternal neonatal and child health (MNCH) services, under-5 clinic, pediatric outpatient services, nutrition services, pediatric antiretroviral therapy (ART) services and primary health care: * Integration of the screening into all the child health care services with introduction of a specific case detection tool and updated presumptive TB register. * Improvement of diagnosis capacities and their integration in all levels of care and all services.

Sponsors & Collaborators

  • UNITAID

    collaborator OTHER

  • University of Sheffield

    collaborator OTHER

  • Kenya Ministry of Health

    collaborator OTHER_GOV

  • Cameroon Ministry of Public Health

    collaborator UNKNOWN

  • Elizabeth Glaser Pediatric AIDS Foundation

    lead OTHER

Principal Investigators

  • Appolinaire Tiam, MBChB, MMed · Elizabeth Glaser Pediatric AIDS Foundation

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2021-06-30
Completion
2021-12-31

Countries

  • Cameroon
  • Kenya

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03862261 on ClinicalTrials.gov